Font Size: a A A
Keyword [Chronic myelogenous leukemia]
Result: 181 - 198 | Page: 10 of 10
181. Studies of human chronic myelogenous leukemia in a mouse model
182. 1、The Potential Roles Of PKCβ In Carcinogenesis And Development 2、Activities And Mechanisms Of A Novel Bisindolymaleimide Derivative WK234 Against Chronic Myelogenous Leukemia
183. Study On The Mechanism Of CircMTOR In Imatinib Resistance Of Chronic Myeloid Leukemia
184. Retrospective Analysis Of Clinical Data Of Chronic Myelogenous Leukemia Patients With Non-hodgkin’s Lymphoma At Different Stages
185. Prospective Study Of Tyrosine Kinase Inhibitor Withdrawal In Patients With Chronic Myelogenous Leukemia In Chronic Phase
186. Evaluating The Effect Of TKI On Aorta In Zebrafish Model
187. 14,15-EET Promote Colony Forming Via Activating PI3K-AKT Pathway In Chronic Myelogenous Leukemia
188. Clinical Study On Expression Of Bcl-2in Chronic Myelogenous Leukemia
189. Analysis Of Clinical Characteristics Of Extramedullary Blast Crisis In Chronic Myelogenous Leukemia
190. A Study On Suolafeini’s Effect And Mechanism On K562 R Leukemia Cells
191. Design,Synthesis And Activity Of Novel Tyrosine Kinase Inhibitors Containing Quinazolinamide Structures
192. Neogambogic Acid(NGA)induces Apoptosis In FLT3-ITD(+)AML Through Degrading FLT3 And Increasing Intracellular Reactive Oxygen Species Level
193. Clinical Observation Of Qinghuang Decoction In The Treatment Of Chronic Myeloid Leukemia With Toxic Heat Flaring Syndrome
194. Research On The Effect And Mechanism Of Interferon Inhibiting PI3K/AKT Signaling Pathway To Enhance The Efficacy Of Imatinib On Chronic Myelogenous Leukemia Drug Resistance Mice Model
195. Clinical Characteristics And NK Cell Level Of 52 Patients Predicting TKI Efficacy In Chroic Myelogenous Leukemia
196. Csn-B Combined With Imatinib Induced Apoptosis Of Chronic Myeloid Leukemia Cells Through Nur77/Pim-1/Drp1 Pathway
197. Effect Of Selinexor Combined With Imatinib On Proliferation And Apoptosis Of K562/G01 Cells
198. Expression Of LIGHT/TNFSF14 In Patients With Chronic Myelogenous Leukemia And Its Clinical Significance
  <<First  <Prev  Next>  Last>>  Jump to